Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.315 AUD | -3.66% |
|
-0.75% | +1.15% |
30/04 | Wilsons Upgrades Monash IVF to Overweight from Market-Weight, Price Target is AU$1.58 | MT |
12/04 | RBC Capital Markets Starts Monash IVF Group at New Sector Perform, Price Target is AU$1.50 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.15% | 35Cr | C+ | ||
+25.37% | 8.92TCr | C+ | ||
-23.70% | 7.59TCr | B- | ||
+2.32% | 2.74TCr | C+ | ||
-10.52% | 1.75TCr | B | ||
-0.32% | 1.7TCr | A- | ||
+0.17% | 1.54TCr | A- | ||
+77.22% | 1.37TCr | C- | ||
+78.81% | 1.32TCr | C+ | ||
-25.61% | 1.28TCr | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MVF Stock
- Ratings Monash IVF Group Limited